HopeStage
Back to all studies
CompletedNCT01552837

Brain and Hippocampal Changes During Quetiapine Treatment in Bipolarity

About this titleRead the official source — NCT01552837
Medication studyAges 18–55Germany
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
AachenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2007
Recruitment status
Completed
Enrollment listed in the registry
33
Sponsor
RWTH Aachen University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
Germany
Age range
From 18 Years to 55 Years
Official registry ID
NCT01552837
Official title
Show the full official title

Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Aachen

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is RWTH Aachen University, a university.

Did this study involve medication?

Yes. The study involved medication, including Seroquel.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies